Implementing a medical opinion leader-led management model to promote timely treatment initiation among screen-positive patients with upper gastrointestinal cancer in rural China: a cluster randomised controlled trial protocol.
BMJ OpenSep 30, 2026 (epub)
Ruyue Liu, Chao Zheng, Liyu Wang et al.
✦ AI-curated · Sources linked
In 30 seconds
This cluster randomised controlled trial aims to assess the effectiveness of a medical opinion leader-led management model in reducing treatment initiation time for screen-positive upper gastrointestinal cancer patients in rural China. Conducted across 16 hospitals, the study will enroll at least 372 participants to evaluate the 30-day timely treatment rate as the primary outcome.
Key findings
- The primary outcome is the 30-day timely treatment rate after pathological diagnosis.
- At least 372 participants will be enrolled in the study.
- The intervention includes WeChat-based health education and face-to-face consultations.
Why it matters
Timely treatment initiation is crucial for improving outcomes in upper gastrointestinal cancer. This study explores a novel approach to enhance treatment access in rural settings, potentially informing future healthcare strategies.